Precision BioSciences.
American gene editing company
- Reports this week
- 1
- Active events
- 0
- Connections
- 26
What's happening
Earlier this month
Gone quiet
No new reports in 90+ days-
Precision BioSciences listed its shares on the electronic stock exchange on July 1, 2026.Some support5 reports
-
A company submitted a request for Rare Pediatric Disease Designation to the FDA.Well supported5 reports
-
FDA fast-tracking of a therapy involving Precision BioSciences, Arrowhead Pharmaceuticals, and Gilead Sciences began on July 1, 2025.Speculative1 report1 development inside
-
Precision BioSciences headquarters is located in Durham, NC, and Tanna serves as VP of Investor Relations.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Precision BioSciences this week
News at the entities that move Precision BioSciences most-
FDA StructuralThe FDA approved Tonix Pharmaceuticals' drug, Tonmya, for use in treating fibromyalgia.Moves Precision BioSciences
-
Nasdaq StructuralFlanagan joins Citi's Board of Directors and takes on leadership roles at Cyabra, a Nasdaq-listed company.Moves Precision BioSciences
-
Regeneron Pharmaceuticals OperationalAndrew J. Murphy has been appointed Co-Chief Scientific Officer at Regeneron Pharmaceuticals.Moves Precision BioSciences
-
Benzinga Mentioned togetherBenzinga reported on Cirrus Logic stock, which is listed on Nasdaq, following a price target cut by Susquehanna.Moves Precision BioSciences
-
Jefferies Financial Group Mentioned togetherJefferies Financial Group initiated analyst coverage on IperionX Limited Sponsored ADR stock on October 1, 2026.Moves Precision BioSciences
-
MarketBeat Mentioned togetherMarketBeat reported analyst recommendations for Fidelity Bank, which is held by FB Bancorp, a company based in New Orleans.Moves Precision BioSciences
Connections
The 9 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Precision BioSciences, granting designations such as Fast Track and Rare Pediatric Disease.
-
Amoroso Structural
Amoroso serves as the President and Chief Executive Officer of Precision BioSciences.
-
Nasdaq Structural
Precision BioSciences is a publicly traded company listed on the Nasdaq stock exchange.
-
Regeneron Pharmaceuticals Operational
The two companies are actively competing against each other within the biotechnology sector.
-
Benzinga Mentioned together
Benzinga reports on Precision BioSciences' stock rating.
-
MarketBeat Mentioned together
MarketBeat provides consensus ratings and financial analysis for Precision BioSciences.
-
Durham Shared context
Precision BioSciences is headquartered and operates within Durham, NC.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group issued a stock rating report on Precision BioSciences.
Show all 9 connections
-
Moldova Shared context
Precision BioSciences conducts clinical trials and investigations within Moldova.
History
Events by the month they beganJuly 2026
1 eventJune 2026
4 events- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.
- A company submitted a request for Rare Pediatric Disease Designation to the FDA.
- FDA fast-tracking of a therapy involving Precision BioSciences, Arrowhead Pharmaceuticals, and Gilead Sciences began on July 1, 2025.
- Precision BioSciences headquarters is located in Durham, NC, and Tanna serves as VP of Investor Relations.